Ignite Creation Date:
2025-12-25 @ 4:15 AM
Ignite Modification Date:
2025-12-26 @ 3:14 AM
Study NCT ID:
NCT05464420
Status:
COMPLETED
Last Update Posted:
2024-09-24
First Post:
2022-07-12
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Safety, Tolerability, Immunogenicity, and Lot Consistency of V116 in Adults 18 to 49 Years of Age (V116-004, STRIDE-4)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-08-12
Start Date Type:
ACTUAL
Primary Completion Date:
2023-05-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-05-25
Completion Date Type:
ACTUAL
First Submit Date:
2022-07-12
First Submit QC Date:
None
Study First Post Date:
2022-07-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-04-26
Results First Submit QC Date:
None
Results First Post Date:
2024-05-24
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-09
Last Update Post Date:
2024-09-24
Last Update Post Date Type:
ACTUAL